STAAR Surgical Jumps After Q1 Beat, Wedbush Upgrades to Outperform
STAA shares rise following $93.5M Q1 2026 revenue, exceeding expectations and driving a rating upgrade on China recovery. STAAR Surgical shares surged after reporting $93.5M in Q1 2026 revenue, surpassing analyst estimates. The company attributed the gain to a rebound in i